Viscosupplementation in Patients With Hemophilic Arthropathy
NCT01748201 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2013-09-10
Summary
Hemophilia is a recessive X chromosome linked genetic disorder of blood coagulation that affects about one in every ten thousand people. Hemarthrosis, which you can begin in childhood, promptly leads to degenerative changes of the articular cartilage which culminate in deformity and degenerative changes early, known as hemophilic arthropathy, which is the most common complication of hemophilia. Aside administration of clotting factor, treatment should address the degenerative changes already present in patients joints. Our objective is to evaluate the effectiveness of articular washing followed by infiltration with corticosteroids and hylan G-F 20, followed by a program of home exercises and/or academy as the previous level of hemophilia patients, in relation to pain relief, and improved function and quality of life.
Conditions
- Osteoarthritis
- Hemarthrosis
- Hemophilia A
- Hemophilia B
Interventions
- PROCEDURE
-
Joint lavage and viscosupplementation
The joint will be washed until obtaining translucent liquid and not hemorrhagic. Then it will receive an intra-articular injection of 6ml of hyaluronic acid (Synvisc One), 1ml of triamcinolone and 2 ml of ropivacaine.
Sponsors & Collaborators
-
University of Sao Paulo General Hospital
lead OTHER
Principal Investigators
-
Marcia U Rezende, Phd · FMUSP
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- Brazil
Study Locations
More Related Trials
-
Topical and Intravenous Administration of TXA Are Equally Effective in DAA THA
NCT01940692 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty
NCT03825939 ·Status: TERMINATED ·Phase: PHASE4
-
Reinfusion Drains vs Tranexamic Acid in Total Joint Arthroplasty
NCT01636414 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Tranexamic Acid on Blood Coagulation in Total Hip Arthroplasty Surgery
NCT03897621 ·Status: COMPLETED ·Phase: NA
-
TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL
NCT03019198 ·Status: COMPLETED ·Phase: PHASE4
-
Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA
NCT03631355 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty
NCT01260818 ·Status: UNKNOWN ·Phase: NA
-
Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty
NCT02926651 ·Status: WITHDRAWN ·Phase: PHASE4
-
Topical Tranexamic Acid for Total Knee Arthroplasty
NCT00985920 ·Status: COMPLETED ·Phase: PHASE4
-
Intraarticular Injection of Tranexamic Acid Reduced Postoperative Hemarthrosis in Arthroscopic Anterior Cruciate Ligament Reconstruction
NCT03580018 ·Status: COMPLETED ·Phase: NA
-
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
NCT01683955 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid
NCT03606109 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
NCT01370460 ·Status: COMPLETED ·Phase: PHASE2
-
Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty
NCT02664909 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture
NCT02738073 ·Status: UNKNOWN ·Phase: NA
-
Tranexamic Acid in Revision Total Joint Arthroplasty
NCT02877381 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of IV Tranexamic Acid on the Thromboelastogram in Patients Undergoing Total Hip or Knee Arthroplasty
NCT02648295 ·Status: COMPLETED
-
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
NCT02043132 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement
NCT02540226 ·Status: COMPLETED ·Phase: PHASE4
-
Blood-saving Effect of Combined Intravenous Tranexamic Acid With Topical Floseal® Application Total Hip Arthroplasty
NCT03623789 ·Status: UNKNOWN ·Phase: PHASE4
-
Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty
NCT02393963 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Predictive Algorithm for a Hemoglobin Value of Less Than 10 g/dl Postoperatively in Scheduled Hip or Knee Arthroplasty
NCT05605860 ·Status: COMPLETED
-
Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty
NCT02747615 ·Status: COMPLETED ·Phase: PHASE4
-
Tranexamic Acid (TXA) in Hip Arthroscopy
NCT05710146 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty
NCT03359525 ·Status: UNKNOWN ·Phase: PHASE4